glp 1 china More Chinese biotechs challenge GLP-1 dominance in diabetes Could China's New Ozempic-like Drugs

Description

Using health record data, the research team tracked more than 42,000 adults already taking at least two types of blood pressure medications

We interviewed 3 users who got a semaglutide prescription form Ro Weight Loss

Get insights on navigating GLP-1 antagonist shortages and compounds as we navigate demand and supply challenges.

However, further research is needed to fully understand how these therapies exert their effect on body weight and in the last section we cover open questions about the potential mechanisms of multiagonist drugs, and the understanding of how gutbrain communication can be leveraged to achieve sustained body weight loss without adverse effects.